<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00923494</url>
  </required_header>
  <id_info>
    <org_study_id>H-24506</org_study_id>
    <nct_id>NCT00923494</nct_id>
  </id_info>
  <brief_title>Effectiveness of Ultrasound (US) Guided Supraclavicular Block</brief_title>
  <official_title>Effectiveness of Ultrasound Guided Supraclavicular Brachial Plexus Block With 20, 30, or 40 ml of Ropivacaine 0.5%</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is being done in order to find out if there is any difference in the
      effectiveness of ultrasound guided supraclavicular brachial plexus nerve block that can be
      achieved with 3 different amounts of ropivacaine 0.5% (20 ml, 30 ml, and 40 ml). The
      investigators want to show if you can have a successful nerve block with less amount of local
      anesthetic, thus potentially decreasing the risk of side effects.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Unable to enroll. Change in patient population.
  </why_stopped>
  <start_date type="Actual">May 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset of analgesia</measure>
    <time_frame>First 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total analgesic use</measure>
    <time_frame>First 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Analgesia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group R20</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive 20 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group R30</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive 30 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group R40</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive 40 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>20 ml of ropivacaine 0.5%</intervention_name>
    <description>Patient will receive 20 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.</description>
    <arm_group_label>Group R20</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>30 ml of ropivacaine 0.5%</intervention_name>
    <description>Patient will receive 30 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.</description>
    <arm_group_label>Group R30</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>40 ml of ropivacaine 0.5%</intervention_name>
    <description>Patient will receive 40 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.</description>
    <arm_group_label>Group R40</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between the ages of 18-64,

          -  Patients who are ASA I-III, presenting for distal upper extremity surgery. Surgeries
             to be considered are ORIF of distal upper extremity fractures such as ORIF radius,
             ORIF ulna, ORIF of any bones in the wrist or hand, and distal upper extremity surgery
             involving bones or tendons for which postoperative pain is to be expected. No
             emergency surgeries will be considered.

        Exclusion Criteria:

          -  Emergency surgery,

          -  Patient or surgeon refusal

          -  Patients for which peripheral nerve block or study medications are contraindicated,

          -  Patients on chronic analgesic therapy at home,

          -  History of nerve injury, neuropathy, or known neurologic injury or illness, or
             inability to properly describe postoperative pain to investigators (language barrier,
             psychiatric disorder, dementia).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaime Ortiz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ben Taub General Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2009</study_first_submitted>
  <study_first_submitted_qc>June 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2009</study_first_posted>
  <last_update_submitted>January 19, 2017</last_update_submitted>
  <last_update_submitted_qc>January 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Jaime Ortiz</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

